Top News
- Fiscal shield tests gilt and FX credibility – BNY
- The US states with the worst and best school systems, ranked
- A startup building a map to help you make plans with friends has doubled its funding
- Jamie Dimon warns stock market and Treasury bond risks underpriced
- Record student loan defaults: 9.5M borrowers in default, data shows
- Nvidia vs Apple: Which tech giant is the better buy?
- Australian Dollar retreats from a monthly high
- GM swallowed a $10.9 billion pill to reset its EV strategy. It says the worst is nearly over.
Browsing: Ordering
Is a $950 test that searches for upwards of 50 types of cancer in your bloodstream worth it? That depends…